sulforaphane has been researched along with Pulmonary Embolism in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Pulmonary Embolism: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "L-sulforaphane was identified as an anticarcinogen that could produce quinine reductase and a phase II detoxification enzyme." | 1.39 | Antiplatelet activity of L-sulforaphane by regulation of platelet activation factors, glycoprotein IIb/IIIa and thromboxane A2. ( Kim, SH; Mo, SJ; Oh, CH; Rhee, YH; Shin, JI; Yun, SJ, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oh, CH | 1 |
| Shin, JI | 1 |
| Mo, SJ | 1 |
| Yun, SJ | 1 |
| Kim, SH | 1 |
| Rhee, YH | 1 |
1 other study available for sulforaphane and Pulmonary Embolism
| Article | Year |
|---|---|
Antiplatelet activity of L-sulforaphane by regulation of platelet activation factors, glycoprotein IIb/IIIa and thromboxane A2.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation; Blood Platelets; Collagen; Female; Fibrinolytic A | 2013 |